Illustration: Shoshana Gordon/Axios
Venture capital fundraising, deal volume and deal count are all down in health tech, but a PitchBook report indicates signs are not all bleak.
Why it matters: The market’s lack of current confidence is obvious, but investors can see where opportunities lie.
